Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Annals of oncology

Results: 101-125/4711

Authors: Ma, B Corry, J Rischin, D Leong, T Peters, LJ
Citation: B. Ma et al., Combined modality treatment for locally advanced squamous-cell carcinoma of the oropharynx in a woman with Bloom's syndrome: A case report and reviewof the literature, ANN ONCOL, 12(7), 2001, pp. 1015-1017

Authors: Seronie-Vivien, S Mery, E Delord, JP Fillola, G Tkaczuk, J Voigt, JJ Bugat, R
Citation: S. Seronie-vivien et al., Carcinocythemia as the single extension of breast cancer: Report of a caseand review of the literature, ANN ONCOL, 12(7), 2001, pp. 1019-1022

Authors: Boccardo, F Miglietta, L Bruzzone, M Rubagotti, A Locatelli, MC Ragni, N
Citation: F. Boccardo et al., Paclitaxel plus organoplatins: Still the gold standard in advanced ovariancancer?, ANN ONCOL, 12(7), 2001, pp. 1023-1024

Authors: Fiorentini, G De Giorgi, U Giovanis, P Guadagni, S Cantore, M Marangolo, M
Citation: G. Fiorentini et al., Intra-arterial hepatic chemotherapy (IAHC) for liver metastases from colorectal cancer: Need of guidelines for catheter positioning, port management,and anti-coagulant therapy, ANN ONCOL, 12(7), 2001, pp. 1023-1023

Citation: 'Electrosmog': What is really behind the fight between Italian Ministers and the Vatican? Smoke again?, ANN ONCOL, 12(6), 2001, pp. 727-727

Citation: Europe and euthanasia, ANN ONCOL, 12(6), 2001, pp. 727-728

Citation: Not everyone is perfect: About off-patent drugs, ANN ONCOL, 12(6), 2001, pp. 728-728

Citation: Cheap drugs? Part 6: A victory for worldwide outrage, ANN ONCOL, 12(6), 2001, pp. 728-729

Citation: About scientific misconduct, ANN ONCOL, 12(6), 2001, pp. 729-730

Citation: EORTC honoured at ASCO and Dr Druker at AACR: The saga of STI-571, ANN ONCOL, 12(6), 2001, pp. 729-729

Citation: Pharmaceutical research projects in cancer have nearly doubled in just sixyears, ANN ONCOL, 12(6), 2001, pp. 729-729

Citation: Perhaps not everyone knows that ..., ANN ONCOL, 12(6), 2001, pp. 730-732

Authors: Levi, F La Vecchia, C
Citation: F. Levi et C. La Vecchia, Tobacco smoking and prostate cancer: Time for an appraisal, ANN ONCOL, 12(6), 2001, pp. 733-738

Authors: Khuri, FR Herbst, RS Fossella, FV
Citation: Fr. Khuri et al., Emerging therapies in non-small-cell lung cancer, ANN ONCOL, 12(6), 2001, pp. 739-744

Authors: Pedersen, MW Meltorn, M Damstrup, L Poulsen, HS
Citation: Mw. Pedersen et al., The type III epidermal growth factor receptor mutation - Biological significance and potential target for anti-cancer therapy, ANN ONCOL, 12(6), 2001, pp. 745-760

Authors: Giles, GG Severi, G McCredie, MRE English, DR Johnson, W Hopper, JL Boyle, P
Citation: Gg. Giles et al., Smoking and prostate cancer: Findings from an Australian case-control study, ANN ONCOL, 12(6), 2001, pp. 761-765

Authors: Gebbia, V Testa, A Borsellino, N Ferrera, P Tirrito, M Palmeri, S
Citation: V. Gebbia et al., Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: A new highly active chemotherapeutic regimen, ANN ONCOL, 12(6), 2001, pp. 767-772

Authors: Dowling, AJ Panzarella, T Ernst, DS Neville, AJ Moore, MJ Tannock, IF
Citation: Aj. Dowling et al., A retrospective analysis of the relationship between changes in serum PSA,palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer, ANN ONCOL, 12(6), 2001, pp. 773-778

Authors: Backus, HHJ van Riel, JMGH van Groeningen, CJ Vos, W Dukers, DF Bloemena, E Wouters, D Pinedo, HM Peters, GJ
Citation: Hhj. Backus et al., Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer, ANN ONCOL, 12(6), 2001, pp. 779-785

Authors: van Putten, JWG Kerbush, T Smit, EF van Rijswijk, R Beijnen, JH Sleijfer, DT Groen, HJM
Citation: Jwg. Van Putten et al., Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer, ANN ONCOL, 12(6), 2001, pp. 787-792

Authors: Alexopoulos, A Kouroussis, C Malamos, N Kakolyris, S Kalbakis, K Kosmas, C Mavroudis, D Agelaki, S Vlachonicolis, J Sarra, E Rigatos, G Georgoulias, V
Citation: A. Alexopoulos et al., Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase II study, ANN ONCOL, 12(6), 2001, pp. 793-798

Authors: Ferreira, CG van der Valk, P Span, SW Jonker, JM Postmus, PE Kruyt, FAE Giaccone, G
Citation: Cg. Ferreira et al., Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients, ANN ONCOL, 12(6), 2001, pp. 799-805

Authors: Guitera-Rovel, P Lumbroso, J Gautier-Gougis, MS Spatz, A Mercier, S Margulis, A Mamelle, G Kolb, F Lartigau, E Avril, MF
Citation: P. Guitera-rovel et al., Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases, ANN ONCOL, 12(6), 2001, pp. 807-811

Authors: Rovella, V Carrara, S Cogliandolo, S Crucitti, A Coco, C Magistrelli, P Lucci-Cordisco, E Anti, M Neri, G Genuardi, M
Citation: V. Rovella et al., Familial microsatellite-stable non-polyposis colorectal cancer: Incidence and characteristics in a clinic-based population, ANN ONCOL, 12(6), 2001, pp. 813-818

Authors: Berclaz, G Altermatt, HJ Rohrbach, V Kieffer, I Dreher, E Andres, AC
Citation: G. Berclaz et al., Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast, ANN ONCOL, 12(6), 2001, pp. 819-824
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>